Literature DB >> 12044237

Cancer fatigue--more data, less information?

Susan B LeGrand1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044237     DOI: 10.1007/s11912-002-0001-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  46 in total

1.  Cancer fatigue: one drug fails but more are in the pipeline.

Authors:  C McNeil
Journal:  J Natl Cancer Inst       Date:  2001-06-20       Impact factor: 13.506

Review 2.  The biologic basis of fatigue.

Authors:  H B Gutstein
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 3.  Progress in understanding fatigue associated with breast cancer treatment.

Authors:  I J Sadler; P B Jacobsen
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

4.  Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy.

Authors:  F Dimeo; S Fetscher; W Lange; R Mertelsmann; J Keul
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

5.  Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients.

Authors:  G Berglund; C Bolund; T Fornander; L E Rutqvist; P O Sjödén
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 6.  Fatigue management: evidence and guidelines for practice.

Authors:  V Mock
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 7.  Psychostimulants in supportive care.

Authors:  J Homsi; D Walsh; K A Nelson
Journal:  Support Care Cancer       Date:  2000-09       Impact factor: 3.603

8.  Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

Authors:  J Glaspy; R Bukowski; D Steinberg; C Taylor; S Tchekmedyian; S Vadhan-Raj
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

9.  A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.

Authors:  W Breitbart; B Rosenfeld; M Kaim; J Funesti-Esch
Journal:  Arch Intern Med       Date:  2001-02-12

10.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.